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Abstract
Objectives The traditional time trade-off (TTO) method
has some problems in the valuation of health states con-
sidered worse than dead. The aim of our study is to com-
pare two TTO variants that address this issue: lead-time
and lag-time TTO.
Methods Quota sampling was undertaken in June 2011 in
Buenos Aires as part of the EQ-5D-5L Multinational Pilot
Study. Respondents were randomly assigned to one of the
TTO variants with two blocks of five EQ-5D-5L health
states. Tasks were administered using a web-based digital
aid (EQ-VT) administered in a group interview.
Results A total of 387 participants were included [mean
age 38.85 (SD: 13.97); 53.14 % females]. The mean
observed values ranged from 0.44 (0.59) for state 21111 to
0.02 (0.76) for state 53555 in the lead-time group and
between 0.53 (0.52) and 0.08 (0.76) in the lag-time group.
There were no statistically significant differences in the
values between TTO variants, except for a significant dif-
ference of 0.19 for state 33133. In both variants, marked
peaks were observed around the value 0 across all states,
with a higher percentage of 0 responses in the last state
valued, suggesting ordering effects.
Conclusions No important differences were found
between TTO variants regarding values for EQ-5D-5L
health states, suggesting that they could be equivalent
variants. However, differences between the two methods
may have been obscured by other aspects of the study
design affecting the characteristics of the data.
Keywords Time trade-off  Lead-time TTO  Lag-time
TTO  Worse than dead  EQ-5D-5L  Quality of life
JEL Classification I10  C93  D01
Introduction
Time trade-off (TTO) is one of the most widely used
methods for valuing health-related quality of life. Many of
the EQ-5D value sets—generated in countries ranging from
the UK [1] to the USA [2], Japan [3], the Netherlands [4],
France [5], and Argentina [6]—were elicited from the gen-
eral population using TTO. With TTO one finds the value for
each health state (Hi) by establishing the amount of time in
full health (x) that is considered equivalent to a given amount
of time in a poor health state (t). That value is calculated as
(x/t). In EQ-5D valuation studies, t is set at 10 years.
Despite its widespread application, there are some prob-
lems with TTO, especially regarding the valuation of states
that are considered ‘worse than dead’ (WTD) [7] because the
trade-off procedure employed for WTD is different than the
one used for states deemed better than dead (BTD).
Accordingly, different TTO elicitation techniques are used
for BTD and WTD. The TTO values for BTD are obtained
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by varying the years spent in full health (x), while the length
of time spent in the health state (Hi) that is to be evaluated is
fixed (t). The procedure for WTD, in contrast, involves
simultaneously changing both x and t.
Several researchers have noted the problems related to
this approach. Above all, they question the assumption that
both procedures produce utilities on the same scale,
pointing out the possibility of obtaining extremely negative
values for WTD [8, 9]. Such issues have far-reaching
implications for the use of TTO values in health technology
assessment and economic evaluations.
In 2006 Robinson and Spencer [10] proposed a solution
to these problems: a new elicitation procedure capable of
yielding values both above and below zero. The method
involves simply adding some additional time in full health
to the time available for trading (‘Life A’), as well as to the
scenario comprising the state being valued (Hi) (‘Life B’).
In the latter, the time in full health precedes the scenario of
illness presented in the TTO task, hence its description as a
lead-time TTO; see Fig. 1. The objective of the task, as in
conventional TTO, is to find a point of indifference
between the two options. When the health state to be val-
ued is considered better than dead, the point of indifference
will be reached when the duration of Life A is longer than
the period of years in full health offered in Life B. If the
health state is considered worse than dead, at the point of
indifference the duration of Life A will be shorter than the
years in full health presented in Life B.
In lead-time TTO, the iterative trading process allows the
participant to move between negative and positive values
without being required explicitly to think about whether the
state is worse or better than being dead. Unlike the con-
ventional approach, lead-time TTO does not require a sep-
arate method of elicitation for these states. Thus, it avoids
the ‘focusing effect’ that may arise with such deliberation.
The question remains whether the resulting values\0 con-
cur with the states judged as worse than being dead [11].
Devlin et al. [12] have shown that lead-time TTO is a
feasible method for the valuation of health states in EQ-5D.
They have provided evidence that this method may change
the values for both BTD and WTD. Some questions
regarding the length of time in full health to be presented in
Life A and the adequate ratio of time in full health (lead-
time) to time in Hi presented in Life B have been explored
[11]. Some of these issues warrant further investigation,
however.
A related TTO variant called lag-time TTO has also
been proposed. It places the additional time in full health
after the health state to be valued instead of before it, as in
lead-time TTO [7, 13] (Fig. 1). The method is therefore
similar to that of lead-time TTO except for the temporal
repositioning of time spent in poor health in Life B. Devlin
et al. [11] investigated the difference between lead-time
and lag-time TTO in the UK and also investigated the
effect on values of offering varying amounts of time in full
health relative to the duration of Hi.
Some authors suggest that, disregarding potential prob-
lems with time preference and framing effects, the valua-
tions should theoretically be the same for both lead- and
lag-time TTO. Nonetheless, it is possible for the variants to
differ in other respects (i.e., the two approaches differ in
the placement of the poor health state relative to dead, so
preferences regarding health at the end of life may lead to
differences in values) [13].
The aim of this study is to understand how the temporal
placement of the additional time in full health—either
before (lead-time TTO) or after (lag-time TTO) the sub-
optimal health state—influences the valuation of EQ-5D-
5L health states.
Methods
This study is part of the EQ-5D-5L Multinational Pilot
Study conducted in the UK, the USA, Canada, the Neth-
erlands, Singapore, China, Spain, and Argentina. The core
design compared lead-time TTO to discrete choice mod-
eling [14]. Each of the country studies tested different
aspects of the core protocol.
Sample
The sample was drawn from the general population of the
city of Buenos Aires and its metropolitan area, covering
individuals between 18 and 80 years of age. The selection
of participants was entrusted to IPSOS, a private survey
consultancy specialized in social and marketing research.
The pilot was held in two locations, Buenos Aires City and
Lomas de Zamora City (in the metropolitan area) between
30 May and 3 June 2011. In order to assure the represen-
tativeness of the sample [15], quota sampling by gender,
age, and socioeconomic status was performed. Data were
collected in group interviews using a digital aid.
Life A Life B
10 yrs full health15 yrs full health 5 yrs Hi
Lag time TTO
Life A Life B
10 yrs full health15 yrs full health 5 yrs Hi
Lead time TTO
Fig. 1 Lead-time and lag-time TTO variants
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Design
Interview scripts and a digital aid were developed to
present each variant of the TTO. As shown in Fig. 1,
Options A and B were displayed horizontally using the
same colors to represent a particular state (green for full
health and blue to represent Hi). The iterative process used
to reach the point of indifference was automated within the
EQ-VT digital aid [14]. Additionally, the EQ-VT captured
all participants’ responses to the task and the amount of
time they needed to complete it.
Response tasks
The tasks, instructions, follow-up, and feedback questions
comply with standard procedures for translation and back-
translation from English to Argentinean Spanish. The IECS
researchers (VI, LRA) attended two training workshops in
the Netherlands in order to standardize the interview pro-
tocol. They replicated this protocol in three workshops in
Buenos Aires with two other IECS researchers (FA, NE)
and the IPSOS team of interviewers.
The protocol replicated the one that was used in the core
multinational pilot study, which included lead-time TTO, a
discrete choice (DC) model (paired comparisons), and the
visual analog scale [14]. The informed consent form was
adapted and approved by the Hospital Italiano de Buenos
Aires Institutional Review Board (IRB) in May 2011.
The study used a split-sample design, whereby a random
half of the sample would get lead-time TTO and the other
half lag-time TTO. All the tasks were administered using
EQ-VT. The interview began with a warm-up exercise of
self-rated health, followed by ten paired comparisons per
participant. The pairs in the DC task were selected on the
basis of a blocked design with 20 blocks of 10 pairs (total
number of states evaluated = 400). The DC task was
followed by TTO valuations of five EQ-5D-5L states (total
number of states evaluated by TTO = 10).
To conduct the Argentinean arm of the multinational
study, we selected one variant of lead-time TTO and one of
lag-time TTO, with a duration of 5 years for the health
state to be evaluated and 10 years of full health (2:1 ratio).
This ratio was selected in light of the results of a previous
study conducted by Devlin et al. in the UK [11]. For the
TTO task, respondents were randomly assigned to one of
two fixed blocks of states, each composed of mild, mod-
erate, and severe health states. They were then instructed to
use either a lead-time TTO or a lag-time TTO method.
Both the DC and the TTO tasks were preceded by a brief
animation sequence designed to explain and illustrate what
they were supposed to do. Upon completion of the task, the
participants were asked a series of follow-up questions.
They were asked to evaluate the difficulty and their
understanding of the tasks, to give some background
information, and to answer some structured feedback
questions.
Analysis
For TTO responses, the mean, median, standard deviation,
and interquartile range (IQR) were calculated. To analyze
the difference between lead-time TTO and lag-time TTO
groups, we performed a t test. The primary comparison
variable comprised the values obtained through the two
TTO methods and its differences. These two variants were
also compared in other aspects: (1) procedural aspects
(time spent by the respondents on each task, number of
steps taken to reach the point of indifference for each
health state; number of times the respondent reset the
protocol and how understandable it was; proportion of
subjects that took a different number of steps before
reaching the point of indifference); (2) logical
Table 1 Sample characteristics
(demographics) and EQ-5D-5L
responses
Lead-time TTO Lag-time TTO p (t test/v2)
Number of participants (%) 209 (52) 178 (48)
Age (years) mean/SD 39.2/13.7 38.9/14.4 0.81
Female n (%) 107 (51.2) 94 (52.8) 0.75
Educational level achieved
(high school or higher)
92.8 % 88.8 % 0.17
EQ-5D-5L
No mobility problems 88.5 % 91.6 % 0.32
No self-care problems 96.2 % 97.2 % 0.58
No limitation of usual activities 88 % 92.1 % 0.18
No pain or discomfort 60.8 % 68.5 % 0.11
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inconsistencies between pairs of health states in each of the
blocks; (3) the relationship between the health-state values
and the severity of the valued states. Severity is measured
using a ‘misery index,’ an additive representation of the
levels of the five dimensions. The misery index for the EQ-
5D-5L ranges from 1 ? 1 ? 1 ? 1 ? 1 = 5 (for the state
of full health, 11111) to 5 ? 5 ? 5 ? 5 ? 5 = 25 (for the
worst health state defined by the EQ-5D-5L descriptive
system, 55555). All statistical analyses were conducted
using STATA MP 9.2.
Results
A total of 414 participants between 18 and 80 years old
were interviewed. Twenty-seven subjects were excluded
from the analysis because they had given the same value to
all five health states presented. Also, 17 tasks that had been
performed in less than a second were excluded under the
premise that the task had not been understood. The lead-
time variant was performed by 209 subjects, while 178 did
the lag-time variant. There were no significant differences
between the groups regarding baseline characteristics and
their self-reported state of health, nor between the 27
excluded participants and the rest of the sample (see
Table 1). Subjects’ characteristics were similar to those of
the general population of Argentina, except for the sub-
jects’ higher educational level [15].
No significant differences were found regarding the
values obtained in both groups for all the evaluated states,
except for a statistically significant difference of 0.19 in
state 33133 (p = 0.04). Table 2 shows the mean and
median values for each of the states. The scatter graph
shows the amount of agreement between lead-time and lag-
time TTO means (see Fig. 2). Values for lead-time were
higher than those for lag-time for states of intermediate
severity, while the reverse was the case for the extremes
(both the mild and the severe states).
The mean observed values per EQ-5D-5L state for lead-
time and lag-time TTO are shown in Fig. 4 in the
‘‘Appendix’’. The values ranged from 0.53 for 21111 to
0.08 for 53555 for lag-time TTO and between 0.44 and
0.02 for lead-time TTO.
Marked peaks around zero were observed in all the
valued states, as shown in Fig. 3. A significant number of
respondents valued the states presented as similar to being
dead (365 responses). Between 60 and 70 percent of them
took only two steps to make this choice. In search of an
explanation for this phenomenon, the presence of an order
effect was explored. We found a greater percentage of
responses U = 0 in the last state valued compared with the
first (27.1 vs. 16.2 percent in lead-time TTO and 23.32 vs.
Table 2 Health-state values by TTO variant
State Lead-time TTO Lag-time TTO t test (mean)
n Mean (SD) Median (IQR) n Mean (SD) Median (IQR) p value Diff (CI 95 %)
21111 109 0.44 (0.59) 0.6 (0, 0.95) 85 0.53 (0.51) 0.7 (0, 1) 0.27 -0.09 (-0.25; 0.07)
12112 99 0.52 (0.50) 0.6 (0.3, 1) 92 0.42 (0.65) 0.58 (0, 0.9) 0.22 0.1 (-0.06; 0.27)
11221 107 0.57 (0.49) 0.7 (0.4, 1) 83 0.51 (0.53) 0.7 (0.3, 1) 0.38 0.07 (-0.08; 0.21)
52221 100 0.19 (0.68) 0.38 (0, 0.6) 91 0.15 (0.69) 0.3 (-0.2, 0.6) 0.71 0.04 (-0.16; 0.23)
11145 109 0.42 (0.56) 0.5 (0, 0.95) 85 0.3 (0.61) 0.4 (0, 0.9) 0.15 0.12 (-0.04; 0.29)
33133 100 0.45 (0.58) 0.5 (0, 1) 90 0.26 (0.64) 0.48 (0, 0.8) 0.04 0.19 (0.01; 0.36)
44113 99 0.16 (0.62) 0 (-1, 0.6) 90 0.13 (0.72) 0.1 (-0.2, 0.75) 0.75 0.03 (-0.16; 0.22)
52324 108 0.19 (0.67) 0.1 (0, 0.7) 85 0.2 (0.70) 0.4 (0, 0.8) 0.9 -0.01 (-0.21; 0.18)
55523 107 -0.03 (0.54) 0 (-0.6, 0.5) 82 0.11 (0.75) 0.05 (-0.1; 0.7) 0.2 -0.14 (-0.35; 0.08)
53555 100 0.02 (0.76) 0 (-0.25, 0.5) 92 0.08 (0.76) 0.15 (-0.4, 0.6) 0.57 -0.06 (-0.28; 0.15)
Lead-time TTO
























Fig. 2 Mean health-state values by state and TTO variant
S28 F. Augustovski et al.
123
13.71 percent in lag-time TTO). Regarding the percentage
of non-trading responses (where poor health is valued at 1),
we found no difference between lead-time and lag-time
TTO (19.65 vs. 19.54 percent, p = 0.95).
From each block of five states that the participants
valued, at least two of the states could be logically ordered
(i.e., 44223 vs. 12112). The extent to which there was
logical consistency was compared between the lead-time
TTO and lag-time TTO groups. There were no differences
regarding consistency between the blocks or TTO variants.
The level of inconsistency was high (41.2 % in block 1 and
46.9 % in block 2).
A subgroup analysis was carried out, excluding the
states in which the values were assessed in two steps. The
goal of the analysis was to avoid potential bias. No major
differences were found between lead-time TTO and lag-
time TTO. The difference found in the original analysis for
state 33133 disappeared, while a new one emerged for state
11145. The mean difference was 0.24 (p = 0.02).
There were no significant differences between the lead-
time and lag-time TTO groups in their responses to the
follow-up questions, nor did these groups differ in the way
the participants responded to the tasks (the amount of time
they needed to value each health state, the number of steps
they took to reach indifference in the TTO tasks, etc.).
Ninety percent of the participants found the instructions
clear and easy to understand, while half had some difficulty
deciding on their answer. It is noteworthy that just over
half of the participants indicated that when valuing the poor
health states, they took into account the possibility that a
new treatment or relief would be available. More details on
this perspective are provided in the ‘‘Appendix’’.
Discussion
Lead-time and lag-time TTO are relatively new variants that









































Fig. 3 Valuation distribution for three health states: mild (upper graph), moderate (lower graph) and severe (middle graph)
Lead versus lag-time trade-off variants S29
123
The EuroQol Group chose to incorporate the lead-time TTO
in their EQ-5D-5L pilot valuation [14] study in an effort to
overcome the known issues. As one of the sub-studies of the
multinational EQ-5D-5L pilot study, we compared the two
TTO variants (lead-time and lag-time TTO) in order to
determine whether there were differences between them.
There are few studies in the literature comparing these
variants; most focus on lead-time TTO exclusively [7, 11,
12], and none used the EQ-5D-5L instrument. One study
[11], which included three variants of lead-time TTO and
one of lag-time TTO, found that none of the variants had
either a systematically higher or lower proportion of val-
ues [0 across all states. The lag-time variant gave con-
siderably higher values for the severe states compared to its
lead-time counterpart. This difference was attributed purely
to the positioning of poor health first and full health later.
The lag-time variant also completely eliminated ‘non-
trading’ responses; even in very mild health states, all
participants were willing to trade at least some time.
Our pilot was conducted in a sample from the general
population of Argentina. The analysis focused on testing
for potential differences between the lead-time and lag-
time TTO, in terms of both the EQ-5D-5L values produced
and various measures of the ‘process’ by which participants
arrived at those values. This was a randomized study, and
the population characteristics were similar across the
groups, making comparisons between them more valid.
Minor imbalances in the number of subjects assigned to
each group—arising from technical problems with the EQ-
VT in the initial phase of recruitment—have no bearing on
the results and interpretation of the study.
We found no relevant differences in the health-state values
generated by the two methods or in the process (number of
steps taken by participants to reach the point of indifference
and the amount of time to complete the protocol). Some of
the states had higher values in the lag-time TTO group, while
the opposite was true for other states. Only one state was
found to be statistically different between the two variants.
An unexpected observation made in both lead-time and
lag-time TTO—and something that has also been observed
in all countries in the multinational pilot study using the
lead-time TTO variant—was that a substantial peak occurred
around 0 in all health states. This peak probably explains the
low mean values produced for mild states in this study, but
also the high level of inconsistency. This finding—the peak
in values at 0—has not been previously reported in studies
using lead-time TTO [3, 11, 12]. Therefore, a likely expla-
nation would lie in the interview protocol for this study: it
used a digital aid in a group setting without personalized
assistance (there was one interviewer for every ten partici-
pants who were being interviewed at the same time). The
time to complete the task was also unexpectedly short,
suggesting that the participants may not have had adequate
concentration and could have rushed to complete the task.
This conclusion is also suggested by the EQ-VT iteration
process. In that process, for all states, the second step in the
TTO tasks involved (as a ping-pong technique) going to a
value of 0; from there, the participants had the choice of
declaring indifference (in which case their value was
recorded as 0) or moving between options above or below a
value of 0. The large proportion choosing a value of 0 after
only two steps suggests that participants were tempted to
finish the task earlier. They then reached the indifference
point without thinking about the fact that they were assign-
ing the health state a value of ‘as bad as being dead.’ These
results should thus be interpreted bearing this fact in mind.
In conclusion, we did not find any meaningful or sys-
tematic differences between the lead-time and lag-time
TTO variants. There are two alternative explanations for
our findings: (1) the results are eclipsed by the nature of the
group interview protocol, which produced a high number
of states valued as zero; or (2) both variants are equivalent.
In order to eliminate the potential noise introduced by the
interview protocol, future research should administer TTO
tasks in face-to-face interview settings. So doing would
promote the engagement of the participants and thereby be
conducive to a valid set of preference data.
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Appendix
See Tables 3, 4, 5 and Fig. 4.
Table 3 Blocks of states
State no. MO SC UA PD AD
Block 1 1 1 2 1 1 2
2 5 2 2 2 1
3 3 3 1 3 3
4 4 4 1 1 3
5 5 3 5 5 5
Block 2 6 2 1 1 1 1
7 1 1 2 2 1
8 5 2 3 2 4
9 5 5 5 2 3
10 1 1 1 4 5
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Fig. 4 Mean observed values per EQ-5D-5L state for lead and lag-
time TTO
Table 4 Cognitive debriefing: different levels of agreement, per-





Instructions were clear 89.5 92.2
Questions were easy to understand 90.0 90.5
It was difficult to decide the answer 49.0 50.6
The difference between the lives
presented was easy to tell
82.8 83.8
The time they asked to imagine was too
long
32.7 34.5
A new treatment or relief was possible 55.3 56.5
I will get used to living with impairment 50.5 46.4
The most important thing is if I would
able to work
72.6 66.1
Difficult to imagine the health states 56.8 53.1
Table 5 Respondents’ process in performing the task (per each
health state evaluated)
Lead-time TTO Lag-time TTO
No. of resets? 0 94.5 % 94.9 %
1 4.4 % 4.5 %
2 1 % 0.5 %
3 0.1 % 0.1 %








Less than 1 min (%)q 73.9 % 72.2 %
? Number of times participants reset the valuation of one health state
$ Number of clicks made by the participant to value one health state (1
click was necessary to select the indifference point by clicking the button
‘‘A&B are the same’’)
D Time in seconds needed to complete the valuation of one health state
q Participants (%) who used less than a minute to value one health state
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